PlexusDx's precision-wellness approach acknowledges that genetic variations in GLP-1 receptor sensitivity, metabolic processing, and appetite regulation pathways may influence both efficacy and tolerability for individual patients
The efficacy and safety of dipeptidyl peptidase-4 inhibitors for type 2 diabetes: A Bayesian network meta-analysis of 58 randomized controlled trials
Furthermore, these drugs are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Figure 1 In non-alcoholic fatty liver disease (NAFLD) mice (23), liraglutide was shown to inhibit the MKK4/JNK signaling pathway, thereby improving the hypoadiponectinemia-induced inflammatory stress
Insulin should be also considered when adequate glycemic control is not obtained in patients with decompensated hepatic or renal insufficiency and when patients have suffered from myocardial infarction, stoke, or a major operation [9]
